Evaluation of the automated collection and extended storage of apheresis platelets in additive solution

Transfusion

Volumn 52, Issue 3, 2012, Pages 503-509

  Johnson, Lacey ^a   Winter, Kelly M ^a   Hartkopf Theis, Tanja ^a   Reid, Samantha ^a   Kwok, Matthew ^a   Marks, Denese C ^a  

^a Research and Development   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CYTOKINE; GLUCOSE; LACTIC ACID;

ACIDITY; ARTICLE; AUTOMATION; CELL ISOLATION; CELL VIABILITY; COMPARATIVE STUDY; COMPUTER PROGRAM; CYTOKINE RELEASE; GLUCOSE INTAKE; HUMAN; THROMBOCYTE ACTIVATION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS;

ACETATES; BICARBONATES; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; CYTOKINES; GLUCOSE; HUMANS; LACTIC ACID; PLATELET ACTIVATION; PLATELETPHERESIS; SOFTWARE; SOLUTIONS; TIME FACTORS;

EID: 84858281023     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03314.x     Document Type: Article

References (26)

1. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A,. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006; 108: 3210-5.
2. Silliman CC, Fung YL, Ball JB, Khan SY,. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev 2009; 23: 245-55.
3. Gathof BS, Tauszig ME, Picker SM,. Pathogen inactivation/reduction of platelet concentrates: turning theory into practice. ISBT Sci Ser 2010; 5: 114-9.
4. Ringwald J, Walz S, Zimmermann R, Zingsem J, Strasser E, Weisbach V, Eckstein R,. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Vox Sang 2005; 89: 11-8. (Pubitemid 40839545)
5. Ringwald J, Haager B, Krex D, Zimmermann R, Strasser E, Antoon M, De Schrijver E, Eckstein R,. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets. Transfusion 2006; 46: 942-8. (Pubitemid 43800912)
6. + platelet additive solution. Vox Sang 2006; 91: 41-6. (Pubitemid 43822303)
7. Ringwald J, Zimmermann R, Eckstein R,. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006; 20: 158-64.
8. Gulliksson H, AuBuchon JP, Vesterinen M, Sandgren P, Larsson S, Pickard CA, Herschel I, Roger J, Tracy JE, Langweiler M,. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82: 131-6. (Pubitemid 36806452)
9. Gulliksson H, AuBuchon JP, Cardigan R, van der Meer PF, Murphy S, Prowse C, Richter E, Ringwald J, Smacchia C, Slichter S, de Wildt-Eggen J,. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 2003; 85: 199-205. (Pubitemid 37247803)
10. Diedrich B, Sandgren P, Jansson B, Gulliksson H, Svensson L, Shanwell A,. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94: 96-102.
11. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD,. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
12. Bertolini F, Murphy S,; for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Transfusion 1996; 36: 128-32. (Pubitemid 26070875)
13. VandenBroeke T, Dumont LJ, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon JP, Gulliksson H, Dengler T, Hornsey V, Prowse C,; for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang 2004; 86: 183-8. (Pubitemid 38529508)
14. Hartley PS, Savill J, Brown SB,. The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets. Thromb Haemost 2006; 95: 100-6.
15. Johnson L, Winter KM, Reid S, Hartkopf-Theis T, Marschner S, Goodrich RP, Marks DC,. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011. 101: no. doi: 10.1111/j.1423-0410.2011.01477.x.
16. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 16th ed. Strassbourg, France: Council of Europe Publishing; 2010.
17. Picker SM, Schneider V, Oustianskaia L, Gathof BS,. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 2009; 49: 2311-8.
18. Ness PM, Campbell-Lee SA,. Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol 2001; 8: 392-6. (Pubitemid 33032922)
19. Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H,. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Transfusion 2006; 46: 973-9. (Pubitemid 43800916)
20. Gulliksson H,. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003; 17: 209-15. (Pubitemid 36900328)
21. Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI,. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008; 48: 847-56. (Pubitemid 351614913)
22. Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G,. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion 2011; 51: 808-15.
23. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P,. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006; 90: 279-85.
24. Cardigan R, Sutherland J, Wadhwa M, Dilger P, Thorpe R,. The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage. Vox Sang 2003; 84: 28-35. (Pubitemid 36564983)
25. Flesch BK, Adamzik I, Steppat D, Miller J, Carstensen L, Schapke M, Davey J,. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort. Transfusion 2010; 50: 894-901.
26. Macher S, Sipurzynski-Budraß S, Rosskopf K, Rohde E, Griesbacher A, Groselj-Strele A, Lanzer G, Schallmoser K,. Function and activation state of platelets in vitro depend on apheresis modality. Vox Sang 2010; 99: 332-40.